Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors

Lancet

Volumn 359, Issue 9323, 2002, Pages 2088-2089

  Adam, Albert ^a   Cugno, Massimo ^b   Molinaro, Giuseppe ^a   Perez, Melissa ^a   Lepage, Yves ^a   Agostoni, Angelo ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE P; ARGININE CARBOXYPEPTIDASE; BRADYKININ; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; QUINAPRIL; RAMIPRIL;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; ENZYME ACTIVITY; ENZYME DEGRADATION; FEMALE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0037097061     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08914-6     Document Type: Article

References (5)

1. Drug-induced angioedema without urticaria
2. Plasma bradykinin in angio-oedema
3. Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma
4. Inhibition of aminopeptidase P potentiates wheal response to bradykinin in angiotensin-converting enzyme inhibitor-treated humans
5. Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor